- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07706322
Adapting a Sexual Assault Prevention Intervention for Transgender Undergraduates: A One-Arm Pilot Trial (TEA3)
10 juli 2026 uppdaterad av: Sarah Peitzmeier
Adapting a Sexual Assault Prevention Intervention for Transgender Undergraduates
The purpose of this study is to adapt and pilot a sexual assault prevention intervention for transgender and nonbinary (trans) undergraduate students.
Forty percent of trans individuals (i.e., individuals whose gender identity does not align with their sex assigned at birth, inclusive of nonbinary people) are sexually assaulted during their time in college.
Despite the magnitude of this issue, there are no sexual assault prevention interventions that have lowered victimization of trans students.
The Enhanced Assess, Acknowledge, Act (EAAA) intervention is recommended by the Centers for Disease Control and Prevention (CDC) and is the only intervention proven to lower rape victimization by over 50% among cisgender female undergraduates.
However, trans-specific vulnerabilities to violence are not addressed in EAAA, nor in the online adaptation of EAAA recently piloted by the study team called internet-delivered EAAA (IDEA3).
This project will adapt and pilot IDEA3 for trans and nonbinary students to develop one of the first evidence-based sexual assault prevention interventions for trans and nonbinary young adults.
We will adapt IDEA3 for trans students ages 18-25 and test it in an initial group which we will use to make revisions to the program.
Then, we will collect participant survey and focus group data on feasibility and acceptability from 4 more groups of participants, revising the intervention between groups.
Finally, we will collect preliminary data on whether the program increased participants' confidence in their ability to defend themselves.
Studieöversikt
Status
Har inte rekryterat ännu
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Beräknad)
80
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studiekontakt
- Namn: Sarah Peitzmeier, PhD
- Telefonnummer: 301-405-2463
- E-post: speitzme@umd.edu
Studera Kontakt Backup
- Namn: Michelle Choi, MA
- Telefonnummer: 301-405-8740
- E-post: mmchoi@umd.edu
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
Tar emot friska volontärer
Ja
Beskrivning
Inclusion criteria:
- Participants must be adults ages 18 to 25, AND
- Have a gender identity that differs from their sex assigned at birth (e.g. trans or nonbinary) AND
- Be an undergraduate student AND
- Be available during the program times, AND
- Provide the contact information for another trans or nonbinary undergraduate who they would be willing to participate in the intervention with OR express willingness to being partnered with another trans or nonbinary undergraduate at their university AND
- Have access to and willingness to use the videoconferencing software Zoom for the program AND
- Consent to being recorded while participating.
Exclusion Criteria:
- Participant is less than 18 years of age or older than 25 years of age, OR
- Does not identify as a trans or nonbinary individual, OR
- Is not an undergraduate student, OR
- Is not available during the program times, OR
- Does not provide the contact information for another trans or nonbinary undergraduate student who they would be willing to participate in the intervention with AND does not express a willingness to being partnered with another undergraduate OR
- Does not have access to and or is unwilling to use the videoconferencing software Zoom, OR
- Does not consent to being recorded while participating.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Övrig
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: TEA3 Intervention
|
Delivery of TEA3 intervention, a 15-hour online sexual assault resistance intervention for transgender undergraduates.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Interventionsdeltagares självförsvarseffektivitet
Tidsram: Inom en vecka efter den sista interventionssessionen
|
Detta kommer att bedömas från deltagarnas svar på baslinje- och eftertestundersökningar som använder validerade skalor för att mäta självförsvarseffektivitet (dvs.
förtroende för att man skulle kunna försvara sig mot sexuella övergrepp)
|
Inom en vecka efter den sista interventionssessionen
|
|
Feasibility of TEA3 intervention
Tidsram: Within one week of the final intervention session
|
This will be assessed by reviewing speed of recruitment and noting no-shows (at first session), overall session attendance, and retention rates for the online intervention to determine whether incentives are sufficient for a future larger trial; reviewing fidelity to the original intervention based on reviewing recordings of all online intervention sessions; reviewing and cataloging deviations from the manual; and final review of what pieces of TEA3 went well and what pieces need to be further adapted in the future.
|
Within one week of the final intervention session
|
|
Acceptability of TEA3 intervention
Tidsram: Within one week of the final intervention session
|
This will be assessed from summary statistics calculated from survey questions completed by participants relating to dimensions of affective attitude (how the individual feels about the intervention); burden (perceived effort required to participate); ethicality (extent to which the intervention fits with the individual's value system), perceived effectiveness, and whether they would recommend the intervention to a friend.
|
Within one week of the final intervention session
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Efficacy of TEA3 intervention
Tidsram: Within one week of the final intervention session
|
This will be assessed from participant answers to baseline and post-test surveys that use validated scales to measure five intermediary outcomes that account for EAAA's effect on reducing victimization: earlier detection of risk in coercive situations; greater risk perception of acquaintance rape; lower rape myth acceptance; knowledge of, and willingness to use evidence-based forceful verbal and physical resistance in a hypothetical situation; and earlier identification of 'discomfort' and earlier willingness to leave a hypothetical situation.
The sexual assault victimization outcome measure for a future RCT, a validated trans adaptation of the Sexual Experiences Survey, will also be used.
|
Within one week of the final intervention session
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Utredare
- Huvudutredare: Sarah Peitzmeier, PhD, University of Maryland, College Park
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Beräknad)
2 september 2026
Primärt slutförande (Beräknad)
30 april 2027
Avslutad studie (Beräknad)
1 juni 2027
Studieregistreringsdatum
Först inskickad
10 juli 2026
Först inskickad som uppfyllde QC-kriterierna
10 juli 2026
Första postat (Faktisk)
15 juli 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
15 juli 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
10 juli 2026
Senast verifierad
1 juli 2026
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- #1670-1
- N/A (Internal grant) (Annat bidrag/finansieringsnummer: University of Maryland)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
IPD-planbeskrivning
Data from video recordings contain identifiers including participant images and names which cannot be removed, and will therefore remain non-public.
Deidentified survey data from initial screener surveys can be made available upon reasonable request and with IRB approval.
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .